Researchers discovered how to flip the structure of complex drug compounds using a simple reagent, offering a game-changing ...

A combination drug known as BZA/CE may offer a safer alternative to tamoxifen in reducing breast cancer risk and improving ...

Women in midlife face a difficult trade-off. Many in their 40s to 60s face a high risk of breast cancer, especially during ...

How many, if any, cases of nervous system disorders have been reported because of A-C breast cancer chemotherapy? I'm 45 and had treatment at 39 and 40. I now experience a very exaggerated amount of ...

UK medicines watchdog the Medicines and Healthcare Products Regulatory Agency (MHRA) stuck an alert on one batch of the ...

Tamoxifen isn’t just used to shrink tumors or manage cancer growth—it plays a central role in preventing recurrence and ...

For the first time, chemists have discovered a unique way to control and modify a type of compound widely used in medicines, ...

Chemists have discovered for the first time a unique way to control and modify a type of compound widely used in medicines, ...

A daily medication relied on by more than half a million women is under urgent recall after a critical test failure raised ...

The UK's medicines regulator has issued an urgent recall for a batch of Tamoxifen tablets after the pills failed crucial ...

Tamoxifen also reduced the risk for invasive recurrence in the same breast, with a 15-year invasive IBR rate of 11.5% in the no tamoxifen group vs 6% in the yes tamoxifen group.

For patients with “good-risk” ductal carcinoma in situ (DCIS) who underwent breast- conserving surgery and did not receive radiotherapy, tamoxifen significantly decreased the risk of ...